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Abstract Monocytes/macrophages are the ¢rst cells involved in
in£ammation. K-Melanocyte-stimulating hormone (K-MSH) is
known to possess an anti-in£ammatory role induced by a variety
of stimuli ; however, the molecular mechanisms underlying these
e¡ects are not clearly de¢ned. In this report we provide evidence
that K-MSH inhibited serum-activated lipopolysaccharide (SA-
LPS)-induced proteolytic enzyme release, oxidative burst re-
sponse, reactive oxygen intermediate generation, nitric oxide
production, and adhesion molecule expression in monocyte-de-
rived macrophages. K-MSH also inhibited SA-LPS-induced nu-
clear transcription factor UB activation not only in macro-
phages, but also in a T-cell line and human neutrophils
isolated from fresh blood. K-MSH downregulated CD14, but
not interleukin-1 receptor, tumor necrosis factor receptor 1 or
2 from the surface of macrophages. Anti-CD14 antibody was
unable to protect K-MSH-mediated downregulation of CD14.
Overall, our results suggest that K-MSH exerts its anti-in£am-
matory e¡ect by a novel mechanism in macrophages through
downregulating of the endotoxin receptor CD14.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Patients often face problems of sepsis in intensive care units
as a major complication after major surgery mostly due to
trauma, burn injury, pancreatitis etc. Bacterial lipopolysac-
charide (LPS), a component of Gram-negative bacteria which
sheds into the circulation, is the major source of sepsis. LPS
¢nally initiates hypermetabolic shock termed endotoxic
shock,collapsing the coordination of di¡erent organ leading
to multiple organ dysfunction [1]. LPS mediates a number of
biologic manifestations, involving activation of several kinases
and transcription factors followed by an uncontrolled produc-
tion and release of proin£ammatory cytokines such as tumor
necrosis factor (TNF), interleukin (IL)-1, IL-6, IL-8, IL-10,
IL-12 etc., reactive oxygen species, and proteolytic enzymes
[2^4] by cells. LPS interacts with most cells through CD14, a
55-kDa glycophosphatidylinositol (GPI)-anchored membrane
protein expressed on the surface of monocytes, macrophages,
and neutrophils [5,6]. The GPI domain of CD14 acts as a
membrane anchorer and signal transducer [7]. Several pro-
teins, which contain a GPI modi¢cation, play an important
role in leukocyte and macrophage in£ammatory functions [8].
GPI-anchored proteins, present in lipid rafts rich in cholester-
ol and sphingolipids, are needed for membrane sorting and
signal transduction [9,10]. Mice lacking the CD14 gene show
resistance to LPS-induced shock [11] and bone resorption [12].
LPS ¢rst binds to a 55-kDa serum protein named lipopoly-
saccharide binding protein (LBP) which is present in the cir-
culation in normal conditions and this complex (LBP^LPS)
triggers CD14 to activate cell signaling [6,13]. In this study
serum-activated LPS (SA-LPS) was used to induce di¡erent
cells (100 ng of LPS was incubated with 20 Wl of human serum
for 1 h at 37‡C and this mixture was SA-LPS).
Neuropeptides have been implicated in the regulation of a
number of immune responses both in humans and in murine
systems [14]. The K-melanocyte-stimulating hormone (K-
MSH), a tridecapeptide derived from pro-opiomelanocortin,
is found in pituitary, brain, skin, and circulation [15]. K-MSH
is essential for synthesis of melanin in melanocytes [16]. In
addition, it has been shown to in£uence various in£ammatory
or immunological conditions by modulating the function of
neutrophils [17], macrophages [18^21], or lymphocytes [22,23].
The interactions with various cells of the immune system have
been shown to downregulate either the production or the
action of the proin£ammatory cytokines. This e¡ect was cor-
related with a decrease in binding of DNA to nuclear tran-
scription factor UB (NF-UB) [17^19,24^26], suggesting the
downmodulation of the LPS-mediated response which re£ects
the inhibition of production of di¡erent in£ammatory cyto-
kines. In mouse macrophages, K-MSH has been shown to
inhibit the C/EBPL DNA binding activity and this e¡ect is
a major mechanism by which K-MSH inhibits the transcrip-
tion of the NOS2 gene [27]. Neuropeptides have also been
shown to possess antipyretic activity [28^30]. Receptors for
K-MSH have been detected in di¡erent cell types [17,18]. Gel-
danamycin, an antibiotic produced by Actinomyces sp., has
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been shown to inhibit the function of heat shock proteins [31].
Interestingly, this antibiotic has been shown to downregulate
CD14 by internalization followed by accumulation in the en-
doplasmic reticulum [32]. The mechanism underlying the ac-
cumulation of CD14 in the endoplasmic reticulum is not
clearly understood.
So far, the anti-in£ammatory activity of K-MSH has been
shown to be mediated by inhibiting the production of in£am-
matory cytokines through downmodulation of NF-UB or
C/EBP transcription factors. As endotoxin-mediated activa-
tion of in£ammatory responses and septic shock were sup-
pressed by K-MSH, the detailed mechanism of K-MSH-medi-
ated responses induced by LPS was investigated. We also
studied the e¡ect of K-MSH on endotoxin receptor (CD14)
regulation. In this report we provide data to establish that
SA-LPS-mediated in£ammatory responses were suppressed
by K-MSH. For the ¢rst time we provide data on K-MSH-
mediated downregulation of the endotoxin receptor CD14
from the surface of macrophages. This study will be helpful
to understand the molecular mechanism of the K-MSH-medi-
ated anti-in£ammatory response in macrophages.
2. Materials and methods
2.1. Materials
LPS (Escherichia coli 055:B5), K-MSH, nitroblue tetrazolium
(NBT), polymyxin B sulfate, formyl peptide (FMLP), phorbol myr-
istate acetate (PMA), p-nitrophenyl phosphate, p-nitrophenyl L-D-glu-
curonide, Histopaque, dextran sulfate, and goat IgG (anti-rabbit)
were obtained from Sigma (St. Louis, MO, USA). Penicillin, strepto-
mycin, RPMI 1640 medium, and fetal bovine serum were obtained
from Life Technologies (Grand Island, NY, USA). Dihydrorhod-
amine was purchased from Molecular Probes, The Netherlands. Anti-
bodies against p50, p65, melanocortin 1 receptor (MC-1R), iNOS, IL-
1R, TNFR1, TNR2, and CD14 were obtained from Santa Cruz Bio-
technology (Santa Cruz, CA, USA).
2.2. Cell lines and neutrophils
THP-1, Jurkat, U-937, HeLa, NIH 3T3, and H4 cells, obtained
from American Type Culture Collection (Manassas, VA, USA),
were cultured according to their protocol. THP-1 cells were stimulated
with 10 ng/ml PMA for 16 h at 37‡C and then adherent cells were
used as macrophages [33,34]. Cells were mycoplasma-free, as tested by
the Gen-probe mycoplasma rapid detection kit (Fisher Scienti¢c,
Pittsburgh, PA, USA). Polymorphonuclear neutrophils were sepa-
rated from fresh human peripheral venous blood of normal healthy
donors by the Dextran T-500 sedimentation method, followed by
Histopaque gradient centrifugation [35]. The purity of the cells was
examined by Giemsa stain and the viability of the cells was checked
by the trypan blue dye exclusion test. The cell preparation contained
90^95% neutrophils, of which 95^98% were viable [35].
2.3. Enzyme release assay
Macrophages (1U107 cells/ml), suspended in D-phosphate-bu¡ered
saline (PBS) containing glucose (1 mg/ml) and bovine serum albumin
(BSA; 5 mg/ml), were stimulated with SA-LPS at 37‡C in untreated
or K-MSH-pretreated cells. The supernatant was collected and used
for assay of three di¡erent enzymes [35]. Myeloperoxidase, alkaline
phosphatase, and L-D-glucuronidase activities were measured using
orthophenylenediamine, p-nitrophenyl phosphate, and p-nitrophenyl
L-D-glucuronide as substrate respectively.
2.4. Measurement of reactive oxygen intermediates
The production of reactive oxygen intermediates (ROI) was deter-
mined by £ow cytometry as described [36]. Untreated or K-MSH-
treated cells were exposed to dihydrorhodamine 123 and then washed
with PBS. Rhodamine 123 £uorescence intensity resulting from dihy-
drorhodamine 123 oxidation was measured by a FACScan £ow cy-
tometer (Becton Dickinson, Mountain View, CA, USA) with excita-
tion at 488 nm and was detected between 515 and 550 nm.
2.5. Assay for NO synthesis
Synthesis of NO was determined by assaying nitrite, a stable reac-
tion product of NO with molecular oxygen from culture supernatant
[37]. Brie£y, 100 Wl of culture supernatant was allowed to react with
50 Wl of Griess reagent in a 96-well plate and incubated at room
temperature for 15 min. The absorbance (in OD) was measured at
570 nm using culture medium as the blank in all experiments. Nitrite
concentrations were calculated from a standard curve derived from
the reaction of NaNO2 in the assay.
2.6. NF-UB activation assay
To determine SA-LPS-induced NF-UB activation, an electrophoret-
ic mobility shift assay (EMSA) was conducted essentially as described
previously [38]. Brie£y, 8 Wg nuclear extracts (NE) were incubated
with 32P end-labeled double-stranded NF-UB oligonucleotide from
the HIV long terminal repeat, 5P-TTGTTACAAGGGACTTTC-
CGCTGGGGACTTTCCAGGGAGGCGTGG-3P (underline indi-
cates NF-UB binding site) for 30 min at 37‡C, and the DNA^protein
complex formed was separated from free oligonucleotides on 6.6%
native polyacrylamide gel. The speci¢city of binding was also exam-
ined by competition with the unlabeled oligonucleotide. The radio-
active bands from the dried gel were quantitated by PhosphorImager
(Fuji, Japan) using Image Reader software.
2.7. Transfection with NF-UB-SEAP and dominant negative IUBK
(IUBK-DN)
THP-1 cell-derived macrophages were transiently transfected by the
calcium phosphate method with 1 ml medium containing 0.5 Wg NF-
UB promoter DNA linked to the heat-stable secretory alkaline phos-
phatase (SEAP) gene with or without 0.5 Wg plasmid DNA of IUBK
mutants (IUBK-DN) lacking either Ser32 or Ser36 [39]. The total
amount of DNA was maintained at 3 Wg by the addition of the
control plasmid pCMVFLAG1 DNA. After 12 h, cells were treated
with K-MSH for 24 h. The culture-conditioned medium was used for
SEAP activity assay essentially as per the Clontech protocol (Palo
Alto, CA, USA). For transfection control, cells were co-transfected
with L-galactosidase and the activity was assayed from each trans-
fection.
2.8. Detection of di¡erent receptors from cell surface and culture
supernatant
Cells and culture supernatant was collected from macrophages, ei-
ther untreated or K-MSH-treated for di¡erent times at 60% con£uent
culture conditions containing 1 ml medium/well of 6-well plates. Cul-
ture supernatant was concentrated. Brie£y, 1 ml culture supernatant
was taken in Centricon YM-3 tubes (3-kDa cut-o¡), purchased from
Millipore (Bedford, MA, USA), and centrifuged at 3000Ug, 4‡C for
2 h and made about 100 Wl. 50 Wg supernatant proteins were spotted
on a nitrocellulose disc. Nitrocellulose discs were blocked in 5% BSA.
Fresh culture medium (500 Wl) was added in each well. Both cells and
discs were incubated with di¡erent antibodies (IL-1R, TNFR1,
TNFR2, or CD14) for 2 h at 37‡C and then incubated with [125I]IgG
(goat) for 1 h. Then labeled IgG binding was assayed from cells and
discs by washing three times with medium. The binding of [125I]IgG
alone for cells or discs was subtracted from total [125I]IgG binding
preincubated with di¡erent antibodies to get speci¢c binding.
2.9. Membrane preparation
Macrophage membranes were isolated from macrophages (1U107
cells/ml) by lysing the cells in hypotonic bu¡er followed by sucrose
gradient centrifugation as described earlier [40].
2.10. Statistical analysis
All data were analyzed by a Student’s t-test. Samples were run in
triplicate and data represent meanQS.D. Independent experiments
were performed at least thrice.
3. Results
In this study, we examined the e¡ect of K-MSH on SA-
LPS-induced biological responses. Non-adherent THP-1
monocytic cells were converted into adherent macrophages
by PMA (10 ng/ml) in 16 h and these cells were induced
with SA-LPS.
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3.1. Inhibition by K-MSH of SA-LPS responses
3.1.1. K-MSH inhibits SA-LPS-induced myeloperoxidase,
alkaline phosphatase, and L-D-glucuronidase activity. LPS,
when incubated with autologous serum, binds with LBP of
serum and forms the LPS^LBP complex. This complex then
interacts with its cell surface receptor CD14 and induces bio-
logical responses. To detect the role of K-MSH in SA-LPS-
mediated biological responses in macrophages, cells were in-
cubated with K-MSH (100 nM) for 24 h at 37‡C and then
stimulated with di¡erent concentrations of SA-LPS for 2 h at
37‡C. Culture supernatant was then used to analyze myelo-
peroxidase, alkaline phosphatase, and L-D-glucuronidase (Fig.
1A). The absorbance for myeloperoxidase and L-D-glucuron-
idase, but not for alkaline phosphatase was enhanced with
increasing concentrations of SA-LPS, whereas K-MSH-pre-
treated macrophages showed no induction of myeloperoxidase
and L-D-glucuronidase activity with di¡erent concentrations
of SA-LPS. The results are mean OD of triplicate assays.
From these results it is clear that the release of SA-LPS-medi-
ated proteolytic enzymes is inhibited by K-MSH.
Fig. 1. A: E¡ect of K-MSH on SA-LPS-induced enzyme release. Macrophages were treated with 100 nM K-MSH for 24 h and then stimulated
with di¡erent concentrations of SA-LPS for 2 h. The supernatant was collected and analyzed for myeloperoxidase, alkaline phosphatase, and
L-D-glucuronidase. The results shown are representative of three independent experiments. B: E¡ect of K-MSH on SA-LPS- and FMLP-induced
oxidative burst response. Macrophages were treated with di¡erent concentrations of K-MSH for 24 h and then stimulated with 100 ng/ml
SA-LPS and 100 nM FMLP for 2 h. Then the NBT test was carried out. NBT-positive and -negative cells were counted under the microscope;
NBT-positive cells are presented in percent. C: E¡ect of K-MSH on SA-LPS-induced NO production. Macrophages were treated with 100 nM
K-MSH for 24 at 37‡C and then stimulated with di¡erent concentrations of SA-LPS for 6 h. The nitrite concentration in the supernatants was
then measured as described in Section 2. D: E¡ect of K-MSH on SA-LPS-induced ROI generation. Cells, either untreated or pretreated with
K-MSH (100 nM) for 24 h, were stimulated with di¡erent concentrations of SA-LPS for 4 h. ROI generation was assayed as mean channel
number by dihydrorhodamine in a £ow cytometer. E: E¡ect of K-MSH on SA-LPS-induced ICAM-1 expression. Macrophages, either untreated
or K-MSH (100 nM)-pretreated for 24 h, were stimulated with di¡erent concentrations of SA-LPS for 12 h. Then cell extract proteins were as-
sayed for ICAM-1 by Western blot. The same blot was re-probed to detect tubulin by Western blot to show equal loading of extract proteins.
F1: E¡ect of K-MSH on SA-LPS-induced NF-UB activation. Macrophages (2U106/ml) were treated with di¡erent concentrations of K-MSH
for 24 h at 37‡C in a CO2 incubator and then stimulated with SA-LPS (100 ng/ml) for 2 h. NF-UB was assayed from 8 Wg NE proteins. The
result shown is representative of three independent experiments. F2: Supershift of NF-UB band. SA-LPS-induced NE was incubated for 15 min
with di¡erent antibodies and cold NF-UB oligonucleotide and then assayed for NF-UB. G: E¡ect of polymyxin B sulfate on SA-LPS-induced
NF-UB activation. 10 Wg of polymyxin B sulfate was incubated with SA-LPS for 1 h at 37‡C and then this mixture was added to macrophages
for 2 h at 37‡C. NE were prepared and assayed for NF-UB by EMSA. H: E¡ect of K-MSH on SA-LPS-induced NF-UB-dependent reporter
gene expression. Macrophages were transiently transfected without (H1) or with IUBK-DN plasmid (H2) along with NF-UB-containing plasmid
linked to the SEAP gene. The cells were cultured for 12 h, treated with 100 nM of K-MSH for di¡erent times and then stimulated with
SA-LPS for 4 h. Culture supernatant was taken and assayed for SEAP. The data shown are representative of three independent experiments.
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3.1.2. K-MSH inhibits SA-LPS-, but not FMLP-induced
oxidative burst response. That LPS and FMLP induce mac-
rophages to generate reactive oxygen species (ROS) is well-
established [35]. The generation of ROS is detected by the
NBT test. To detect the role of K-MSH in SA-LPS-mediated
ROS generation, macrophages were treated with di¡erent con-
centrations of K-MSH for 24 h and then stimulated with 100
ng/ml SA-LPS and 100 nM FMLP for 2 h at 37‡C in the
presence of NBT solution (0.1%). NBT-positive cells were
counted under the microscope and are presented in percent
above unstimulated cells (Fig. 1B). K-MSH did not increase
the number of NBT-positive cells alone like in unstimulated
cells. SA-LPS and FMLP induced 82% NBT-positive cells
(P6 0.001). K-MSH inhibited SA-LPS-induced but not
FMLP-induced NBT-positive cells. These data indicate that
K-MSH downregulates the SA-LPS-, but not the FMLP-in-
duced oxidative burst response suggesting speci¢c activity of
K-MSH.
3.1.3. K-MSH inhibits SA-LPS-induced NO production.
To detect the role of K-MSH on SA-LPS-induced NO pro-
duction, macrophages were treated with K-MSH (100 nM) for
24 h and then stimulated with di¡erent concentrations of SA-
LPS for 6 h at 37‡C. The culture supernatant was collected
and then analyzed for NO using Griess reagent. The concen-
tration of NO was determined from the standard curve ob-
tained from the reaction of NaNO2 (P6 0.001). The results in
Fig. 1C indicate that SA-LPS induced NO production in a
dose-dependent manner. K-MSH inhibited SA-LPS-induced
NO production at all concentrations.
3.1.4. K-MSH inhibits SA-LPS-induced ROI generation.
ROI generation is an intermediate step for di¡erent bio-
logical responses. To detect the role of K-MSH in SA-LPS-
induced ROI generation, macrophages were treated with
K-MSH (100 nM) for 24 h and then stimulated with di¡erent
concentrations of SA-LPS for 4 h. Then ROI generation was
examined with dihydrorhodamine dye conversion to rhoda-
mine as described in Section 2. SA-LPS-induced ROI gener-
ation was shown in a dose-dependent manner and K-MSH
inhibited ROI generation at all concentration of SA-LPS
(Fig. 1D).
3.1.5. K-MSH inhibits SA-LPS-induced ICAM-1 expres-
sion. As K-MSH inhibited di¡erent SA-LPS-induced biolog-
ical responses, the expression of intracellular adhesion mole-
cule (ICAM-1) was detected. Macrophages were treated with
K-MSH (100 nM) for 24 h and then stimulated with di¡erent
concentrations of SA-LPS for 12 h. Then 100 Wg cell extract
proteins were analyzed in 9% sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis (SDS^PAGE) and ICAM-1
was detected by Western blot analysis. Fig. 1E shows that
SA-LPS induced ICAM-1 expression in a dose-dependent
manner but K-MSH-pretreated cells failed to induce ICAM-
1 expression by varying concentrations of SA-LPS, suggesting
Fig. 1 (Continued).
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K-MSH-mediated inhibition of SA-LPS-induced biological re-
sponses in macrophages. Upon re-probing the gel with anti-
tubulin antibody, we found that the band intensities in all
lanes were uniform indicating equal loading of extracted pro-
tein in the lanes.
3.1.6. K-MSH inhibits SA-LPS-induced NF-UB activa-
tion. To detect the role of K-MSH in endotoxin-induced
NF-UB activation, macrophages were treated with di¡erent
concentrations of K-MSH for 24 h at 37‡C and then stimu-
lated with 100 ng/ml SA-LPS for 2 h at 37‡C. NE was pre-
pared and 8 Wg NE proteins were analyzed in 6.6% native
PAGE to detect NF-UB by gel shift assay. The results in
Fig. 1F1 indicate that K-MSH alone did not activate
NF-UB, but SA-LPS-induced NF-UB activation was inhibited
in a dose-dependent manner and at 100 nM concentration
K-MSH completely abrogated SA-LPS-induced NF-UB activa-
tion. From this result, it is clear that K-MSH alone does not
alter NF-UB activation but inhibits SA-LPS-induced NF-UB
activation. Various combinations of Rel/NF-UB proteins can
constitute an active NF-UB heterodimer that binds to speci¢c
sequences in DNA. To show that the retarded band visualized
by EMSA in SA-LPS-induced cells was indeed NF-UB, we
incubated the NE from SA-LPS-activated cells with antibod-
ies p50 (NF-UBI) and p65 (Rel A) or in combination and then
conducted EMSA. Antibodies to either subunit of NF-UB
shifted the band to a higher molecular weight (Fig. 1F2),
thus suggesting that the SA-LPS-activated complex consisted
of p50 and p65 subunits. Neither preimmune serum nor irrel-
evant antibodies such as anti-c-Rel or anti-cyclin D1 had any
e¡ect on the mobility of NF-UB. The complex completely
disappeared in the presence of a 50-fold molar excess of
cold NF-UB indicating its speci¢city for NF-UB.
3.1.7. Polymyxin B sulfate blocks SA-LPS-induced NF-UB
activation. LPS is a glycolipid, and its lipid moiety is known
to be critical for its activity. Polymyxin B, a polycationic
cyclic peptide, is known to bind to the lipid moiety of LPS
and inactivate its activity [41]. To ascertain this exquisite spec-
i¢city for NF-UB activation, we incubated 10 Wg of polymyxin
B sulfate with SA-LPS for 1 h at 37‡C and then this mixture
was added to macrophages for 2 h at 37‡C. NE were prepared
and assayed for NF-UB by EMSA. The results in Fig. 1G
show that polymyxin B by itself had no e¡ect on NF-UB
activation, but it completely abrogated SA-LPS-induced NF-
UB activation.
3.1.8. K-MSH inhibits SA-LPS-induced NF-UB reporter
gene activation. As SA-LPS-induced NF-UB activation was
blocked by K-MSH, NF-UB-dependent gene expression was
also tested. Macrophages were transfected with NF-UB re-
porter plasmid containing the SEAP gene and/or IUBK-DN
plasmid. Cells were treated with K-MSH (100 nM) for di¡er-
ent times at 37‡C and then stimulated with SA-LPS for 4 h.
Culture supernatant was collected and used to assay SEAP
activity. The results in Fig. 1H1 indicate that SEAP activity
was induced by SA-LPS. K-MSH alone had no e¡ect on
SEAP activity but inhibited SA-LPS-induced SEAP activity
in a time-dependent manner. The IUBK-DN-transfected cells
showed the basal activity of SEAP and SA-LPS-mediated
stimulation was completely abrogated by the cells transfected
with IUBK-DN (Fig. 1H2) indicating the speci¢city of the
assay. The L-galactosidase activity from cell extracts showed
almost similar absorbance from di¡erent treatments (as per
Promega protocol) at 420 nm (data not shown) suggesting
the transfection control for each treatment.
3.2. Inhibition of NF-UB activation by K-MSH is
cell type-speci¢c
As NF-UB activation pathways di¡er in many cell types
[42^45], we studied whether K-MSH a¡ects human Jurkat
(T) cells and H4 (glioma) cells and neutrophils isolated from
fresh human blood as well. It has been demonstrated that
distinct signal transduction pathways could mediate induction
in lymphoid, neuronal, and primary cells. All the e¡ects of
K-MSH described above were conducted with macrophages.
We found that K-MSH blocks SA-LPS-induced NF-UB acti-
vation in neutrophils (Fig. 2A) and Jurkat cells (Fig. 2B) in a
dose-dependent manner, but partially in H4 cells (Fig. 2C),
suggesting that this e¡ect of K-MSH is restricted to neutro-
phils and T-cells, but not glioma cells.
3.3. Levels of K-MSH receptors in di¡erent cells
To understand the speci¢city of K-MSH-mediated downre-
gulation of NF-UB, we detected the level of expression of
K-MSH receptors in di¡erent cells. H4, HeLa, and THP-1-
derived macrophages (1U106/well) were plated and incubated
overnight in 12-well plates. U937, Jurkat cells, and neutro-
phils (1U106/sample) were kept on ice in triplicate. Cells
were incubated with 4 ng 125I-labeled K-MSH (5U104 cpm)
for 2 h at 4‡C in the presence or absence of 50-fold cold
Fig. 2. E¡ect of K-MSH on SA-LPS-induced NF-UB activation in
di¡erent cell lines. Human neutrophils isolated from fresh human
blood (A), T-cell (Jurkat) (B), and glioma (H4) (C) cells were
treated with di¡erent concentrations of K-MSH for 24 h and then
stimulated with SA-LPS (100 ng/ml) for 2 h at 37‡C. After these
treatments, NE were prepared and assayed for NF-UB.
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K-MSH and K-MSH binding was assayed. The results are
represented as mean speci¢c binding in cpmQS.D. of tripli-
cate samples (Table 1). The results indicate that the K-MSH
receptors are expressed in macrophages, Jurkat, and neutro-
phils (P6 0.001), which re£ects the K-MSH-mediated down-
regulation of SA-LPS-induced NF-UB activation.
3.4. K-MSH downregulates CD14, but not IL-1R1, TNFR1, or
TNFR2 in macrophages
To detect the e¡ect of K-MSH on the level of di¡erent
receptors, macrophages were treated with 100 nM K-MSH
for di¡erent times. Then cells and culture supernatant (con-
centrated 10 times) were used to assay IL-1R1, TNFR1,
TNFR2, or CD14 using [125I]IgG binding assay as described
in Section 2. Fig. 3 shows that speci¢c binding for IL-1R1
(Fig. 3A), TNFR1 (Fig. 3B), or TNFR2 (Fig. 3C1) was not
changed with varying time of K-MSH incubation either in
cells or in culture supernatant (P6 0.005). The speci¢c bind-
ing of [125I]IgG for CD14 was decreased in cells with increas-
ing time of K-MSH treatment. The level was gradually in-
creased with increasing time of K-MSH treatment of cell
supernatant (Fig. 3D1). The level of TNFR1 was unchanged
in the cell extracts treated with K-MSH as assayed by Western
blot (Fig. 3C2). No TNFR1 was observed in culture super-
natant. The level of CD14 was decreased in the cell extract
with increasing time of K-MSH treatment and the level in-
creased gradually in the supernatant (Fig. 3D2), indicating
that K-MSH induces release of CD14 from the surface of
macrophages but not other receptors like IL-1, TNFR1, and
TNFR2. The almost equal intensity of the alkaline phos-
phatase level from di¡erent lanes shows equal loading of pro-
teins.
3.5. Anti-MC-1R antibody protects K-MSH-mediated
downregulation of SA-LPS-induced NF-UB activation
To detect the speci¢city of K-MSH-mediated inhibition of
SA-LPS-induced biological responses, macrophages (1U106/
well of 6-well plates) were incubated with 1 Wg of anti-mela-
nocortin 1 receptor (anti-MC-1R) antibody for 2 h and then
treated with K-MSH (100 ng/ml) for 24 h. Cells were then
stimulated with SA-LPS (100 ng/ml) for 2 h. NE were pre-
pared, and 8 Wg nuclear proteins were analyzed to detect NF-
UB by gel shift assay. Fig. 4A shows that SA-LPS-induced
NF-UB activation was inhibited by K-MSH. K-MSH-treated
cells did not downregulate SA-LPS-induced NF-UB activation
when cells were preincubated with anti-MC-1R antibody in-
dicating that anti-MC-1R antibody protects K-MSH-mediated
downregulation of NF-UB.
Fig. 3. E¡ect of K-MSH on anti-IL-1R, -TNFR2, -TNFR1, and -CD14 antibody binding. Macrophages were treated with 100 nM K-MSH for
di¡erent times. After treatment, cells and 10 times concentrated culture supernatants (taken in nitrocellulose membrane discs) were incubated
with anti-IL-1R (A), -TNFR2 (B), -TNFR1 (C1), or -CD14 (D1) antibodies. Then speci¢c [125I]IgG (mouse) binding was assayed as described
in Section 2. The cell pellet was extracted and 100 Wg of extract proteins and 50 Wg of culture supernatant proteins were assayed for TNFR1
(C2) and CD14 (D2) level by Western blot analysis. The results shown are representative of three independent experiments.
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3.6. K-MSH downregulates CD14 by secretion from
macrophage cell surface
To detect the mode of CD14 downregulation by K-MSH-
treated macrophages, cells were treated with K-MSH (100
nM) for 24 h and then cell supernatant, plasma membrane
and cytoplasm (including cell organelle) were prepared. Cell
supernatant (100 Wg proteins, after 10 times concentration),
plasma membrane and cytosol (from 1U106 cells) were solu-
bilized in SDS^PAGE sample bu¡er and then analyzed for
CD14 by Western blot analysis. The bands were detected by
ECLPlus reagent (Amersham, IL, USA) and detected in Phos-
phorImager (Molecular Dynamics, Sunnyvale, CA, USA).
The level of CD14 was observed in the membrane fraction
of unstimulated cells and in the supernatant in K-MSH-
treated cells (Fig. 4B). CD14 was not observed in the cytosolic
Table 1
Speci¢c [125I]K-MSH binding to cells
Cells Speci¢c bindingQS.D. (cpm)
H4 1340Q 120
U-937 1230Q 102
THP-1 1672Q 214
Macrophages 3020Q 230
Jurkat 2140Q 210
HeLa 858Q 92
NIH 3T3 812Q 152
Neutrophils 2678Q 156
Di¡erent cells were incubated with [125I]K-MSH for 2 h at 4‡C in
the presence or absence of 50-fold unlabeled K-MSH. The speci¢c
K-MSH binding was assayed after subtracting the non-speci¢c bind-
ing (binding in the presence of 50-fold cold K-MSH) from total
binding (binding in the absence of cold K-MSH). The results indi-
cate mean speci¢c binding (in cpm) of triplicate assays.
Fig. 4. A: E¡ect of anti-MC-1R antibody on K-MSH-mediated downregulation of SA-LPS-induced NF-UB activation. Macrophages, preincu-
bated with anti-MC-1R antibody (1 Wg/ml) for 2 h, were treated with 100 nM K-MSH for 24 h. Cells were then stimulated with 100 ng/ml
SA-LPS for 2 h. NF-UB was assayed from NE. The result is representative of three independent experiments. B: E¡ect of K-MSH on downre-
gulation of CD14. Macrophages were stimulated with K-MSH (100 nM) for 24 h and then culture supernatant (Sup) was concentrated 10-fold
and 100 Wg protein was taken in a tube. The plasma membrane (Mem) and cytoplasm (Cyto) were fractionated from untreated and K-MSH-
treated cells (1U106 cells). The supernatant, membrane and cytosol were boiled in SDS^PAGE sample bu¡er. CD14 was detected by Western
blot. The same blot was re-probed for alkaline phosphatase by Western blot analysis and bands were detected by chemiluminescence by Phos-
phorImager. C: E¡ect of anti-MC-1R antibody on K-MSH-mediated downregulation of CD14. Macrophages, pre-incubated with anti-MC-1R
antibody (1 Wg/ml) for 2 h, were treated with 100 nM of K-MSH for 24 h. The cell extract proteins (100 Wg) and concentrated culture superna-
tant proteins (50 Wg) were analyzed in 10% SDS^PAGE to detect CD14 by Western blot analysis. The same blot was re-probed with alkaline
phosphatase. The result shown is representative of three independent experiments. D,E: Role of anti-CD14 antibody to protect K-MSH-medi-
ated downregulation of CD14 and NF-UB. Macrophages were incubated without or with 1 Wg/ml anti-CD14 antibody for 2 h and then treated
with di¡erent concentrations of K-MSH for 24 h. Cells, then washed with 0.5 M KSCN for 10 s, were incubated with 1 Wg/ml anti-CD14 anti-
body for 2 h followed by [125I]IgG for 1 h at 37‡C and speci¢c binding was assayed (D). After KSCN washing cells were stimulated with
SA-LPS (100 ng/ml) for 2 h, NE were prepared, and assayed for NF-UB by EMSA (E).
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fraction. The equal intensities of alkaline phosphatase bands
indicated the loading control.
3.7. Anti-MC-1R antibody protects K-MSH-mediated
downregulation of SA-LPS-induced NF-UB activation
To detect the role of the melanocortin receptor on K-MSH-
mediated downregulation of CD14, macrophages were incu-
bated with anti-MC-1R antibody (1 Wg/ml) for 2 h and then
treated with K-MSH (100 nM) for 24 h. Then cell supernatant
was collected and concentrated (10 times). The cell pellet was
extracted and 100 Wg extract proteins and 50 Wg cell super-
natant proteins were analyzed in 10% SDS^PAGE and de-
tected for CD14 by Western blot analysis. The results in
Fig. 4C indicate that pretreatment with anti-MC-1R antibody
protected the K-MSH-mediated CD14 downregulation. Re-
probing the blot with anti-alkaline phosphatase antibody
showed the equal loading of proteins.
3.8. Anti-CD14 antibody does not protect K-MSH-mediated
downregulation of CD14 and NF-UB activation
To detect the role of anti-CD14 antibody on K-MSH-medi-
ated CD14 downregulation, macrophages were incubated with
anti-CD14 antibody (1 Wg/ml) for 2 h and then treated with
di¡erent concentrations of K-MSH for 24 h. Cells were then
washed with 0.5 M potassium thiocyanate (KSCN) for 10 s.
The KSCN wash was given to remove anti-CD14 antibody
bound to its receptor [35]. After washing, cells were incubated
with anti-CD14 antibody for 2 h followed by [125I]IgG bind-
ing at 37‡C for 1 h. The speci¢c binding was calculated. The
results in Fig. 4D indicate that K-MSH decreased the CD14
level (by decreasing [125I]IgG binding) at increasing concen-
trations (P6 0.001). A similar pattern of CD14 binding was
shown in cells preincubated with anti-CD14 antibody fol-
lowed by K-MSH treatment and washing with KSCN. From
this result it is clear that anti-CD14 antibody does not protect
K-MSH-mediated downregulation of CD14. Anti-CD14 anti-
body-preincubated macrophages did not show protection to-
wards K-MSH-mediated inhibition of SA-LPS-induced NF-
UB activation (Fig. 4E). These results suggest that anti-
CD14 antibody is unable to protect the K-MSH-mediated
action.
4. Discussion
Even though several studies indicate that certain neuropep-
tides, such as K-MSH, have anti-in£ammatory e¡ects, the
mechanism underlying this e¡ect is not understood. Primarily,
the cells in the brain and pituitary are responsible for produc-
tion of K-MSH. K-MSH interacts through its receptors (MC-
R) [46,47] in di¡erent cells and it also stimulates melanocytes
and other cell types. It was reported that both human and
murine macrophage cell lines and human neutrophils express
MC-R [18,19]. Our data also con¢rm the expression of
K-MSH receptors in di¡erent cell types (Table 1). Thus, it is
likely that the e¡ects of K-MSH described here in macro-
phages and other cells are mediated through activation of
the MC-R. The in£ammatory responses are aggravated by
NF-UB activation due to the NF-UB-dependent gene activa-
tion. It has been reported that K-MSH inhibits NF-UB acti-
vation in the monocytic cell line U-937 [48]. As macrophages
play a central role in responding to a microbial pathogen and
triggering the in£ammation due to bacterial secretion of LPS,
a major component of the outer membrane via the activation
of NF-UB, the regulation of this transcription factor is impor-
tant in macrophages. As LPS ¢rst binds to the serum glyco-
protein LBP and stimulates cells through CD14, we incubated
LPS with autologous serum and this mixture, SA-LPS, which
serves as an endotoxin, was used as an inducer of in£amma-
tion in vitro. LPS is a glycolipid, and its lipid moiety is known
to be critical for its activity. Polymyxin B, a polycationic
cyclic peptide, is known to bind to the lipid moiety of LPS
and inactivate its activity [41]. Polymyxin B sulfate inhibited
SA-LPS-induced NF-UB activation (Fig. 2B), indicating spe-
ci¢c endotoxin-mediated activities in macrophages.
Upon infection, macrophages release several proteolytic en-
zymes to remove microbes in vivo. Stimulation of macro-
phages with SA-LPS led to release of myeloperoxidase and
L-D-glucuronidase and K-MSH inhibited SA-LPS-induced re-
lease of those enzymes but not alkaline phosphatase as de-
tected by enzyme activity assay (Fig. 1A). Myeloperoxidase
and L-D-glucuronidase are released from azurophilic granules
but alkaline phosphatase is released from secretory vesicles
[49]. SA-LPS might activate the macrophages by releasing
the azurophilic contents but not the secretory vesicles. Acti-
vated cells show the oxidative burst response and generate
di¡erent oxygen species. NBT dye converted into formazan
granules reacted with those oxygen species and was deposited
inside the cells. K-MSH inhibited the SA-LPS-induced oxida-
tive burst response as detected by NBT-positive cell count
(Fig. 1B). The oxidative burst response causes generation of
di¡erent reactive oxygen and nitrogen species. K-MSH inhib-
ited SA-LPS-induced nitrite and ROI generation (Fig. 1C,D).
In this report we observed that endotoxin-induced NF-UB
activation was inhibited by K-MSH (Fig. 1F1). K-MSH also
downregulated SA-LPS-induced ICAM-1 expression (Fig.
1E). Expression of adhesion molecules is believed to be medi-
ated by activation of NF-UB which is correlated with the
downregulation of NF-UB (induced by SA-LPS) by K-MSH.
This downregulation of NF-UB was further con¢rmed by NF-
UB-dependent reporter gene (SEAP activity) assay (Fig. 1H).
Several genes such as cytokines, cyclooxygenase-2, metallo-
proteases, urinary plasminogen activator, and cell surface ad-
hesion molecules are involved in in£ammation and tumor
promotion is regulated by NF-UB [50^54]. As K-MSH blocked
NF-UB activation and SEAP expression, so it may play a
critical role in in£ammation exhibiting anti-in£ammatory ef-
fects.
K-MSH-mediated downregulation of NF-UB was observed
not only in macrophages but also in a human T-cell line and
human neutrophils isolated from fresh human blood. How-
ever, why K-MSH did not show downregulation of NF-UB in
human glioma cells is not understood. The level of K-MSH
receptors on the glioma cell surface is lower than on macro-
phages, neutrophils, or T-cells (Table 1). The low level of
K-MSH receptor may be the cause of K-MSH insensitivity
in glioma cells. However, there is no report that Jurkat cells
have CD14 so the downregulation of NF-UB in these cells by
K-MSH might follow some other mechanism like an increase
in cAMP level [48,55] which needs to be further studied.
K-MSH downregulated CD14, an endotoxin receptor from
macrophages, but not TNFR1 and TNFR2 or IL-1 receptors
(Fig. 3). The level of CD14 decreased from macrophages and
it appeared in culture supernatant. CD14 is secreted from the
surface of macrophages by K-MSH treatment. Recently Vega
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and Maio [32] reported that geldanamycin downregulated
CD14 from macrophages and it internalized and localized in
a cytoplasmic organelle, the endoplasmic reticulum. Our re-
sults suggest that K-MSH downregulates CD14 from macro-
phages by secreting from the surface but not by residing in the
cytoplasmic organelles. The anti-CD14 antibody did not pro-
tect K-MSH-mediated downregulation of CD14. The mecha-
nism underlying the K-MSH-mediated secretion of CD14
from the macrophage surface needs to be studied. A possible
role of di¡erent proteases induced by K-MSH cannot be ruled
out. However, in this report we provide a novel mechanism by
which endotoxin-mediated in£ammatory responses are ame-
liorated by K-MSH indicating its anti-in£ammatory activity
in macrophage-mediated in£ammation. Our present study in-
dicates that K-MSH may prove to be a boon in the treatment
of sepsis.
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